PT  - JOURNAL ARTICLE
AU  - Welch, J. P.
TI  - Prevention of congenital rubella
DP  - 1977 Jul 23
TA  - Canadian Medical Association Journal
PG  - 151--156
VI  - 117
IP  - 2
4099  - http://www.cmaj.ca/content/117/2/151.short
4100  - http://www.cmaj.ca/content/117/2/151.full
SO  - CMAJ1977 Jul 23; 117
AB  - The vaccine of choice for rubella vaccination is considered to be RA 27/3, based on frequency of side effects, duration of immunity, antigenic potential and rate of reinfection by wild virus. The most appropriate individuals to be vaccinated are prepubertal schoolgirls and susceptible members of other high-risk groups, and a nationwide immunization program is suggested. Premarital determination of rubella-immune status should be mandatory for all women of childbearing age. A favourable cost/benefit ratio for rubella vaccination seems highly probable. The use of a rubella "fact sheet" to provide education and information for those at risk is strongly recommended.